ArticlePloS one2025
Phytochemical composition and bioactivities of Satureja montana L. and Satureja hortensis L.: Culinary herbs with antidiabetic, anticholinesterase, and antioxidant potential.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Current Knowledge of the GenusPharmaceuticals (Basel, Switzerland) · 2026Review
- Enhanced Toxicity, Physiological Disruption, and Population Growth Suppression Induced by NanoemulsifiedPlants (Basel, Switzerland) · 2026Article
- Characterization of Phenolic and Essential Oil Constituents ofMolecules (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increasing global burden of oxidative stress-related conditions, diabetes, and neurodegenerative disorders underscores the urgent need for multi-targeted, plant-based therapeutic agents. In this context, the present study aimed to evaluate the antidiabetic, antioxidant, and neuroprotective properties of various Satureja hortensis and Satureja montana extracts and essential oils. In vitro biological activities were assessed through α-glucosidase, acetylcholinesterase (AChE), and butyrylcholinesterase (BChE) inhibition assays, along with DPPH• and ABTS• ⁺ radical scavenging assays. At a concentration of 100 µg/mL, S. hortensis root methanol extract (ShRME) and herb water extract (ShHWE) exhibited strong α-glucosidase inhibitory activity (69.88% and 71.23%, respectively). Conversely, S. montana herb water extract (SmHWE) and methanol extract (SmHME) showed the highest DPPH• radical scavenging activity (36.28% and 24.37%, respectively). S. montana essential oil (SmEO) demonstrated notable inhibition of AChE (32.58%) and BChE (41.62%) at 1000 µg/mL, while S. hortensis essential oil (ShEO) inhibited BChE by 44.39%. GC-MS analysis revealed that SmEO primarily contained carvacrol (43.72%), γ-terpinene (17.24%), and p-cymene (14.56%), while ShEO was rich in thymol (39.84%), γ-terpinene (20.16%), and p-cymene (13.72%). These phenolic monoterpenes are likely contributors to the observed antioxidant and cholinesterase inhibitory activities. Principal component analysis explained 74.8% of the total variance and clearly separated the samples based on their activity profiles. Extracts were closely associated with glucose-regulating effects, while essential oils clustered with enzyme-inhibiting neuroprotective activities. These findings highlight the multifunctional therapeutic potential of Satureja species and support their further investigation as candidates for the development of plant-derived agents against oxidative stress, diabetes, and neurodegenerative diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.